semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42334436
Semaglutide for primary prevention of major adverse cardiac and cerebrovascular events in patients with type 2 diabetes and comorbid rheumatoid arthritis: a target-trial emulation.
Semaglutide for primary prevention of major adverse cardiac and cerebrovascular events in patients with type 2 diabetes and comorbid rheumatoid arthritis: a target-trial emulation.
- 저자
- Farheen Malik, Mandar Shah, Yu Chang, Ishmum Chowdhury, Sridhar Mangalesh, Ahmed Ashraf Morgan
- 저널
- European heart journal. Cardiovascular pharmacotherapy
- 공개일
- 2026 Aug 17
- 연구 유형
- 기타
- DOI
- 10.1093/ehjcvp/pvag044
문헌 요약
Rheumatoid arthritis (RA)-related physical limitations often hinder sustained physical activity and weight management, thereby amplifying cardiovascular risk through adverse metabolic profiles and chronic inflammation. We aimed to assess the effectiveness of semaglutide on the risk of incident major adverse cardiovascular and cerebrovascular events (MACCE…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.